Chatziralli I, et al. - Herein, the experts assessed the long-term anatomical and functional outcomes in cases with retinal vein occlusion (RVO), either central retinal vein occlusion or branch retinal vein occlusion, treated with intravitreal ranibizumab. They also assessed the predictive factors of the final visual outcome. Increasing age, increasing macular thickness, the presence of intraretinal fluid, the duration of RVO >3 months, the ischemic type of RVO, the cystoid type of edema, and the external limiting membrane and ellipsoid zone disruption were found to be the negative predictive factors for the final visual outcome.